financetom
Business
financetom
/
Business
/
Update: Fokus Mining Up 22% as it Names a New CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Fokus Mining Up 22% as it Names a New CEO
Oct 23, 2024 9:19 AM

11:53 AM EDT, 10/23/2024 (MT Newswires) -- Fokus Mining ( FKMCF ) late on Tuesday said it appointed Philippe MacKay as its new chief executive, effective Nov. 4.

MacKay previously held the position of mine manager for the Cariboo gold project at the Osisko Group.

"I am fully committed on developing the Galloway Project in this well-known mining district," MacKay said. "My main objective is to deliver maximum value for all Fokus shareholders."

Fokus shares were last seen up $0.02 to $0.11 on the TSX Venture Exchange.

Price: 0.11, Change: +0.02, Percent Change: +22.22

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Next Technology Shares Fall After $9 Million Registered Direct Offering
Next Technology Shares Fall After $9 Million Registered Direct Offering
Sep 2, 2025
01:59 PM EDT, 09/02/2025 (MT Newswires) -- Next Technology ( NXTT ) shares fell 47% in recent Tuesday trading after the company announced a registered direct offering of about 60 million common shares, or pre-funded warrants, priced at $0.15 each for gross proceeds of $9 million. The offering is expected to close on or about Wednesday, the company said. Price:...
AbbVie Says Health Canada Approves Elahere in Some Types of Ovarian Cancers
AbbVie Says Health Canada Approves Elahere in Some Types of Ovarian Cancers
Sep 2, 2025
01:21 PM EDT, 09/02/2025 (MT Newswires) -- AbbVie ( ABBV ) said Tuesday that the Health Canada has approved Elahere for adult patients with folate receptor-alpha positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received one to three prior systemic treatment regimens. The approval came after the drug showed statistically significant and clinically meaningful improvements in...
Market Chatter: Berkshire Hathaway Chair Buffett 'Disappointed' in Kraft Heinz Breakup
Market Chatter: Berkshire Hathaway Chair Buffett 'Disappointed' in Kraft Heinz Breakup
Sep 2, 2025
01:26 PM EDT, 09/02/2025 (MT Newswires) -- Berkshire Hathaway ( BRK/A ) (BRK.A, BRK.B) Chairman and Chief Executive Warren Buffett is disappointed in the planned separation of Kraft Heinz ( KHC ) into two independent publicly traded companies, CNBC reported Tuesday. Buffett said the merger he had masterminded was not a brilliant idea, but he does not think splitting Kraft...
Nestle plunged into crisis as CEO fired for hiding romance with staffer
Nestle plunged into crisis as CEO fired for hiding romance with staffer
Sep 2, 2025
ZURICH (Reuters) -Nestle has fired CEO Laurent Freixe after just a year in the job for concealing a romantic relationship with a subordinate, throwing the Swiss food giant into a leadership crisis that compounds a share price slump and slowing sales. Freixe is replaced by Nespresso chief Philipp Navratil, 49, a rising star at the world's largest food company, as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved